Title : Does combined peroxisome proliferator-activated receptors-agonist and pravastatin therapy attenuate the onset of diabetes-induced experimental nephropathy?

Pub. Date : 2014 Nov

PMID : 25399210






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: Rosiglitazone treatment increased creatinine clearance and plasma transferrin, and decreased urinary ACR, HbA1c, plasma TNF-alpha, ICAM-1, and serum lipid peroxide levels without affecting the altered lipid profile. Rosiglitazone intercellular adhesion molecule 1 Rattus norvegicus